These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32385254)

  • 1. LncRNA Nron regulates osteoclastogenesis during orthodontic bone resorption.
    Zhang R; Li J; Li G; Jin F; Wang Z; Yue R; Wang Y; Wang X; Sun Y
    Int J Oral Sci; 2020 May; 12(1):14. PubMed ID: 32385254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA Nron Inhibits Bone Resorption in Periodontitis.
    Li J; Jin F; Cai M; Lin T; Wang X; Sun Y
    J Dent Res; 2022 Feb; 101(2):187-195. PubMed ID: 34157883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional motif of long noncoding RNA Nron against osteoporosis.
    Jin F; Li J; Zhang YB; Liu X; Cai M; Liu M; Li M; Ma C; Yue R; Zhu Y; Lai R; Wang Z; Ji X; Wei H; Dong J; Liu Z; Wang Y; Sun Y; Wang X
    Nat Commun; 2021 Jun; 12(1):3319. PubMed ID: 34083547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA AK077216 promotes RANKL-induced osteoclastogenesis and bone resorption via NFATc1 by inhibition of NIP45.
    Liu C; Cao Z; Bai Y; Dou C; Gong X; Liang M; Dong R; Quan H; Li J; Dai J; Kang F; Zhao C; Dong S
    J Cell Physiol; 2019 Feb; 234(2):1606-1617. PubMed ID: 30132869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
    Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T
    Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA expression profiles and the negative regulation of lncRNA-NOMMUT037835.2 in osteoclastogenesis.
    Chang Y; Yu D; Chu W; Liu Z; Li H; Zhai Z
    Bone; 2020 Jan; 130():115072. PubMed ID: 31593824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption.
    Binder N; Miller C; Yoshida M; Inoue K; Nakano S; Hu X; Ivashkiv LB; Schett G; Pernis A; Goldring SR; Ross FP; Zhao B
    J Immunol; 2017 May; 198(9):3436-3447. PubMed ID: 28314855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
    Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
    Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleanolic acid exerts inhibitory effects on the late stage of osteoclastogenesis and prevents bone loss in osteoprotegerin knockout mice.
    Zhao D; Shu B; Wang C; Zhao Y; Cheng W; Sha N; Li C; Wang Q; Lu S; Wang Y
    J Cell Biochem; 2020 Jan; 121(1):152-164. PubMed ID: 31318102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption.
    Wang L; Guo X; Zhou W; Ding Y; Shi J; Wu X; Liu Y; Xu Y; Yang H; Geng D
    Acta Biomater; 2018 Jun; 73():488-499. PubMed ID: 29656074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
    Nakagawa S; Omori K; Nakayama M; Mandai H; Yamamoto S; Kobayashi H; Sako H; Sakaida K; Yoshimura H; Ishii S; Ibaragi S; Hirai K; Yamashiro K; Yamamoto T; Suga S; Takashiba S
    Int Immunopharmacol; 2020 Jun; 83():106429. PubMed ID: 32222639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactive glass nanoparticles inhibit osteoclast differentiation and osteoporotic bone loss by activating lncRNA NRON expression in the extracellular vesicles derived from bone marrow mesenchymal stem cells.
    Yang Z; Liu X; Zhao F; Yao M; Lin Z; Yang Z; Liu C; Liu Y; Chen X; Du C
    Biomaterials; 2022 Apr; 283():121438. PubMed ID: 35220020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
    Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
    Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2 activation attenuates both orthodontic tooth movement and relapse.
    Kanzaki H; Shinohara F; Itohiya-Kasuya K; Ishikawa M; Nakamura Y
    J Dent Res; 2015 Jun; 94(6):787-94. PubMed ID: 25795629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrodin inhibits osteoclastogenesis via down-regulating the NFATc1 signaling pathway and stimulates osseointegration in vitro.
    Zhou F; Shen Y; Liu B; Chen X; Wan L; Peng D
    Biochem Biophys Res Commun; 2017 Mar; 484(4):820-826. PubMed ID: 28161640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of DANCR reduces osteoclastogenesis and root resorption induced by compression force via Jagged1.
    Zhang X; Zhao Y; Zhao Z; Han X; Chen Y
    Cell Cycle; 2019 Aug; 18(15):1759-1769. PubMed ID: 31213122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arctigenin inhibits RANKL-induced osteoclastogenesis and hydroxyapatite resorption in vitro and prevents titanium particle-induced bone loss in vivo.
    Wei G; Liang T; Wei C; Nong X; Lu Q; Zhao J
    J Cell Biochem; 2019 Apr; 120(4):5367-5376. PubMed ID: 30317692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
    Zhu M; Liu H; Sun K; Liu J; Mou Y; Qi D; Zhou C; Abudunaibi M; Tasiken B; Li J; Cheng H; Huang H
    Biomed Pharmacother; 2020 Mar; 123():109769. PubMed ID: 31846839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
    Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
    Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.